Fox Business - The Power to Prosper
Search Site

Biotechnology

Treasury takes aim at corporate inversion

FBN’s Liz MacDonald on deal stocks under pressure as the U.S. announces stricter tax rules.

Read More

  1. Stossel 07/31/14: Let us experiment

    Stossel and his family members talk about out-of-the-ordinary things they've tried

  2. The future of 3D-organ-tissue printing

    Organovo Holdings Chief Strategy Officer Dr. Eric Michael David on a $20,000 hospital bill and 3D organ tissue printing.

  3. Market check: TSLA, NFLX, GILD, FB

    FBN’s Nicole Petallides with the latest on the markets.

  4. Denny’s diners dish on fancy NYC debut

    Newoak president James Frischling, Jack Hough of Barrons and FBN’s Tracy Byrnes on Denny’s $300 Grand Slam breakfast at its NYC location.

  5. Fewer international tensions expected to worry markets?

    Pepper International CEO Carol Pepper on her market predictions for the rest of the year.

  6. Where are the investment opportunities in health care?

    Validea Hot List Editor John Reese on where investors can profit in the health-care sector.

  7. S&P winners and losers

    Meridian Equity Partners Jonathan Corpina, Hennessy Funds Portfolio Manager Neil Hennessy, Ira Epstein of The Lynn Group and FBN contributor Phil Flynn discuss which S&P stocks are seeing green.

  8. Esther George’s take on monetary policy

    Former National Economic Council member Philippa Malmgren on the Fed’s policies and how Americans are affected by inflation.

  9. Apple hits new all-time high

    First Trust Advisors chief economist Brian Wesbury and GFI Group director of sales and trading John Spallanzani on Apple and Nasdaq top performers.

  10. Evaluating Google’s performance

    BeaconCrest Capital Management CIO Kevin Divney and S&P Capital IQ’s Rich Peterson on the magic behind Google’s success.

  11. A simple formula for the markets

    Adviser Investments CIO Jim Lowell and Morgan Creek Capital Management CEO Marak Yusko give insight into the markets and Alibaba’s IPO.

  12. Pandora shares get boost from ‘buy’ rating

    FBN’s Adam Shapiro breaks down the day in the markets.

  1. Demandware shares a ‘buy’ or too risky?

    FBN’s Charles Payne, retail analyst Hitha Prabhakar, Penn Financial Group founder Matt McCall and FBN’s Tracy Byrnes on the outlook for Demandware.

  2. Don’t hold your breath: Politics could hold up iPhone 6 in China

    Gerber Kawasaki CEO Ross Gerber and Permanent Portfolio Family of Funds CEO Michael Cuggino explain how the iPhone 6 might not be available in China until the end of the year.

  3. Stocks to watch: COH, SYMC

    See It Market Strategist Ryan Detrick, Al Frank Asset Management CIO John Buckingham and SFG Alternatives CIO Larry Shover on the outlook for stocks.

  4. Stocks to watch: CMG, DIS

    Rosenthal Wealth Management Group President Larry Rosenthal, Spectrum Management Group Managing Partner Bob Phillips, OptionPit.com founder Mark Sebastian and FBN’s Nicole Petallides on the state of the markets.

  5. Byron Wien hot on tech, biotech

    Blackstone Advisory Partners vice chairman Byron Wien discusses the rise in company buybacks and his outlook for the markets.

  6. Leading the way for biotech

    Quintiles CEO Tom Pike talks business in the biotech industry.

  7. Apple announcement’s impact on the tech sector

    Veracruz founder Steve Cortes weighs in on the possible implications following Tuesday’s Apple announcement.

‹ Prev12345Next ›
Freebase CC-BY
Source: Biotechnology on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL